DynaMedex

What DynaMedex does

DynaMedex is a clinical decision support platform operated by EBSCO Industries, Inc., headquartered in Ipswich, Massachusetts, and serving healthcare professionals, hospitals, health systems, academic medical centers, and medical libraries. The platform consolidates multiple evidence-based clinical reference modules into a unified web and mobile product: a Drug Resources database covering dosing, interactions, contraindications, and pharmacokinetics; Chemo Regimens for oncology protocol reference; clinical Calculators for risk and dosing assessment; Patient Info for patient education; Specialty content for clinical disciplines; Alerts for evidence updates; and an Evidence-Based Medicine (EBM) Fundamentals educational resource. Dyna AI, an AI-powered intelligent search and clinical decision support feature, is integrated across the platform to surface relevant clinical content. The product line has operated under EBSCO since at least 1989.

The business model is institutional B2B subscription licensing, sold as enterprise-wide access to healthcare organizations, academic medical centers, and medical libraries. DynaMedex is distributed via the dynamedex.com web platform with institutional authentication and administrative tooling, alongside native iOS and Android mobile applications for point-of-care use. The go-to-market is sales-led and benefits from EBSCO's established enterprise distribution network in healthcare and academic markets. Pricing is not publicly disclosed; contracts are negotiated at the organizational level. DynaMedex sits within EBSCO Industries, a diversified conglomerate, and operates as a profit center within that parent rather than as a standalone venture-backed entity. The customer base is horizontally segmented across healthcare professionals, academic institutions, and enterprise hospital systems, with clinical decision support, drug information lookup, chemotherapy protocol reference, patient education, and evidence-based medicine practice as the primary use cases.

Name

DynaMedex

Legal name

EBSCO Industries, Inc.

Website

https://dynamedex.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

DynaMedex, an EBSCO Industries subsidiary, delivers a B2B clinical decision support platform combining drug databases, chemotherapy regimens, clinical calculators, patient education, and AI-powered search for healthcare professionals, hospitals, and academic medical centers via institutional subscriptions.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

Keywords

• Clinical decision support
• Evidence-based medicine
• Drug information databases
• Medical reference platform
• Clinical decision support software

Headquarters

HQ city

Ipswich

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Institutional Subscription Access: DynaMedex generates revenue through institutional subscription licensing to healthcare organizations, hospitals, academic medical centers, and medical libraries. The subscription model provides organizational-wide access to clinical decision support resources.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

DynaMedex provides a unified clinical decision support platform that combines an evidence-based drug information database, chemotherapy regimen protocols, clinical calculators, specialty-specific content, patient education materials, and an AI-powered search capability (Dyna AI). The platform is sold as an institutional subscription to healthcare organizations, hospitals, academic medical centers, and medical libraries, providing organization-wide access via web and mobile applications.

Product overview

DynaMedex is a unified clinical decision support platform published by EBSCO Industries, Inc. The platform integrates multiple modules including the core Drug Resources database along with specialized modules for Chemo Regimens, Patient Information, Medical Calculators, Specialty-specific content, and an Alerts system. The Dyna AI feature provides intelligent search and retrieval capabilities across the knowledge base. The EBM Fundamentals resource supports evidence-based medicine education. The platform is accessed via web interface and mobile applications.

Differentiator

Problem solved

Functional benefit

Products and services

• DynaMedex Clinical Decision Support Platform

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Direct peers

• UpToDate: UpToDate, operated by Wolters Kluwer, is the leading evidence-based clinical decision support platform used by physicians worldwide. It directly competes with DynaMedex in the same institutional subscription CDS category, targeting the same clinician users with comparable content depth and point-of-care reference functionality.
• Micromedex: IBM Micromedex is a long-established drug information and clinical reference solution historically positioned as a direct competitor to DynaMed in the hospital drug information market. Its drug content and dosing reference capabilities directly overlap DynaMedex's Drug Resources module, making it a clear functional peer in clinical decision support.
• ClinicalKey: ClinicalKey is Elsevier's flagship clinical reference and decision support platform for physicians and healthcare institutions. It competes directly with DynaMedex in the institutional clinical reference category, offering comparable drug, disease, and guideline content with similar subscription licensing to hospitals and health systems.
• Lexicomp: Lexicomp, also part of Wolters Kluwer, is a leading drug information and clinical reference solution widely licensed to hospitals and health systems. It competes directly with DynaMedex's Drug Resources module in institutional drug reference subscriptions, serving the same pharmacy and clinical audiences.
• VisualDx: VisualDx is a clinical decision support platform specializing in image-based differential diagnosis, used by clinicians at the point of care. It directly competes with DynaMedex in the institutional CDS subscription market, addressing overlapping clinician needs for diagnostic and treatment reference.
• First Databank (FDB): First Databank is a provider of drug knowledge and clinical decision support data powering EHR systems, pharmacy platforms, and CDS tools. While more focused on data infrastructure, its drug content directly overlaps DynaMedex's Drug Resources module and serves the same institutional pharmacy and clinical customers.
• Epocrates: Epocrates is a widely-used clinical reference and drug information app serving physicians, nurse practitioners, and pharmacists at the point of care. It directly competes with DynaMedex in clinical reference, particularly for drug information lookups and interaction checking, serving the same clinician persona.
• MDCalc: MDCalc is a clinical decision support platform focused on medical calculators, risk scores, and diagnostic criteria used by clinicians at the point of care. It directly competes with DynaMedex's Calculators module and is widely adopted by the same clinician target audience in hospitals and academic medical centers.
• PEPID: PEPID is a clinical decision support platform providing drug information, disease reference, and clinical calculators to hospitals, pharmacies, and academic institutions. It directly competes with DynaMedex across multiple modules (Drug Resources, Calculators, specialty content) with similar institutional subscription delivery.
• BMJ Best Practice: BMJ Best Practice is a clinical decision support tool published by BMJ that provides evidence-based diagnosis and treatment information to clinicians globally. It directly competes with DynaMedex in the institutional clinical decision support subscription market, with comparable content scope and institutional customer base.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/DynaMedex

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DynaMedex